Second, like SCLC tumor cells, CRAD tumor cells may secrete serum NSE, which correlates with tumor mass extension (Carney et al., 1982), therefore higher level of serum NSE may indicate aggravated tumor burden of the patients. This evidence concerns the gene ENO2 and neoplasm.